Page last updated: 2024-08-18

2-naphthol and ER-Negative PR-Negative HER2-Negative Breast Cancer

2-naphthol has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, YH; Chung, HY; Hwang, NL; Hwang, SY; Im, E; Kang, YJ; Kim, DH; Kim, JA; Kim, ND; Suh, H; Sung, B	1

Other Studies

1 other study(ies) available for 2-naphthol and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model. International journal of oncology, 2017, Volume: 51, Issue:2 Topics: Animals; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MCF-7 Cells; Mice; Naphthols; Resorcinols; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2017

Article

Year

HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.

International journal of oncology, 2017, Volume: 51, Issue:2

Topics: Animals; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MCF-7 Cells; Mice; Naphthols; Resorcinols; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2017